Cargando…
New Strategies Using Antibody Combinations to Increase Cancer Treatment Effectiveness
Antibodies have proven their high value in antitumor therapy over the last two decades. They are currently being used as the first-choice to treat some of the most frequent metastatic cancers, like HER2(+) breast cancers or colorectal cancers, currently treated with trastuzumab (Herceptin) and bevac...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5742572/ https://www.ncbi.nlm.nih.gov/pubmed/29312320 http://dx.doi.org/10.3389/fimmu.2017.01804 |